May 4, 2021
Province of Gauteng South Africa is first to offer an innovative single session keloid treatment without need of surgery
GARCHING, MUNICH, Germany & GAUTENG, South Africa - May 4, 2021 - PRLog -- OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies, announced today that the new Rhenium-188 treatment for keloids is now available in Gauteng, South Africa.
Even though keloids are common throughout the world, their epidemiology has not been adequately investigated. The development of Keloid scars is not only a cosmetic issue but also sometimes painful or limit mobility and may cause deterioration in the quality of life.
The incidence of Keloids in South Africa is very high. According to research in Nigeria, Zambia & South Africa have shown incidence rates are as high as 16% (over 9 million). Some skin types are more prone to Keloids than others, but all can be affected.
Severe cases of Keloids are usually treated by surgery followed by radiation and the prolonged daily use of corticosteroid tape/bandages; however, they tend to recur when they are surgically excised in the absence of adjuvant therapies.
The new Rhenium-188 therapy is now available for Keloid sufferers in South Africa and will be provided by Oncobeta's distribution partner Tautomer (PTY) LTD. This next-generation radionuclide therapy technology applied by nuclear medicine physicians, offers a new single session, painless and effective treatment for keloids. This technology has also been used successfully to date for the treatment of Non-Melanoma skin cancers.
Martin Magwaza, CEO of Tautomer (PTY) LTD also Oncobeta®'s distribution partner for the Rhenium-SCT® (Skin Cancer Therapy) in Africa, is dedicated to providing South Africans with new innovative and effective therapies across the country and African continent, coordinating with representatives from all levels of government and state for the health care landscape.
CEO and Managing Director of OncoBeta® GmbH, Shannon D. Brown III stated "Our ground-breaking technology brings a fantastic new treatment opportunity for people suffering from keloids. It also shows what great potential Rhenium-188 has in the epidermal treatment realm."
About Rhenium-188 treatment
The Rhenium-188 paste is a brachytherapy utilizing the Beta emitter radioisotope Rhenium-188 for epidermal treatments. Rhenium-188 is an isotope with excellent therapeutic advantages that delivers ß-radiation to lesions and minimum dose to the surrounding tissue due to its low penetration in the human tissue (only up to 2-3 mm).
The Rhenium-188 epidermal radioisotope therapy is a painless, personalized, non-invasive therapy targeting and destroying the cells in the area needed to treat. This triggers the treated area to discard defective cells and initiate local immune system reactions letting the body repair itself.
About Tautomer (PTY) LTD
Tautomer is a privately owned, fully integrated Health Technology company based in Centurion, South Africa. Through our network of strategic partners, we engage in the development, manufacturing, and distribution of high-quality Nuclear Medicine based therapies and diagnostics. Tautomer has an extensive pipeline of product candidates under development for various therapeutic indications. The primary focus of Tautomer is to address the unmet medical needs in Oncology, Pain Management, Infectious diseases. Also leveraging scientific and technological advancements to develop solutions that can help expand treatment options for healthcare practitioners and patients in Africa and beyond.
Find out more about Tautomer at https://tautomer.co.za/
About OncoBeta® GmbH
OncoBeta® GmbH with its headquarters located in Garching near Munich, is a privately held medical device company, specializing in the development and commercialization of state-of-the-art, innovative epidermal radioisotope therapies. Since its foundation, OncoBeta® GmbH has concentrated its efforts on the development, regulatory approval(s) and commercialization of therapies such as the Rhenium-SCT® (Skin Cancer Therapy), targeting non-melanoma skin cancers and is now expanding to other epidermal indications such as Keloids. OncoBeta® has successfully perfected the customized application and device management system to perform these therapies in conformity with all health, safety, and environmental protection regulatory standards.
Find out more about OncoBeta® at https://www.oncobeta.com/
Contact
OncoBeta GmbH
[email protected]
+49 (89) 32667330
The Daily Mail's travel desk brings you a selection of the best deals currently available - so you can bag a bargain break.
Von einem schwimmenden Saunadorf bis hin zu einem Restaurant im Ballsaal-Stil: Drei lokale Unternehmer verraten, wo man in Norwegens drittgrößter Stadt essen, entspannen und Kontakte knüpfen kann – und warum das dortige kooperative Miteinander das Arbeiten so bereichernd macht. The post Ist Trondheim der coolste neue Wirtschaftsstandort in Skandinavien? Die Trendsetter vor Ort sind dieser Meinung. appeared first on Business Traveller.
The award-winning composer has created a five-track album which "reflects the emotions, moments and memories that define travel" The post Qatar Airways and Hans Zimmer Unveil Signature Onboard Music appeared first on Business Traveller.
Describing his life-affirming Symphony No 8, composer Gustav Mahler told lyricist and writer Richard Specht in 1906 that he had completed the huge score in a feverish two months. “It was like a lightning vision – I saw the whole piece immediately before my eyes and only needed to write it down, as though it were being dictated to me,” he said. Representing a paradigm shift in his symphonic style and sung from beginning to end, Mahler’s epic eighth in E-flat major was unprecedented, fusing two...
Just here to help you fight seasickness, stay protected from the sun, and have the best time ever on your next cruise. View Entire Post ›
What you need to know about booking, driving and charging an E.V. if your travel plans include a getaway from gasoline-powered engines.
Iowa voters chose Democrat Rob Sand to be their next governor, flipping the seat Republicans have held for more than two decades. Sand defeated Zach Lahn, a first-time candidate who surprised even members of his own party when he won the Republican primary. Sand, who is currently state auditor, has been the only Democrat serving in statewide elected office. His victory will almost certainly make him a leading face of a Democratic Party that he’s kept at arm’s length, focusing instead on his...
Early next year, Virgin Australia’s invitation-only Beyond Lounge returns to the site of The Club in Perth, while Brisbane gains 100 seats and top-tier members get a WhatsApp line to the airline The post More Seats, More Sockets: Virgin Australia to Boost Lounge Offerings in Perth and Brisbane appeared first on Business Traveller.
The drop in prosecutions — and the apparent rise in open usage — coincides with a Public Prosecution Service of Canada policy change in 2020 directing prosecutors away from laying criminal charges for drug possession, according to police officials and experts who spoke with CBC News.
Specialist small group adventure company Explore Worldwide has analysed its latest booking patterns, destination searches and customer behaviour to identify five emerging trends for the year ahead – from looking beyond traditional bucket-list destinations to seeking more meaningful experiences that connect travellers with local people, cultures and wildlife. The findings come as Explore reaches a milestone of more than 50 Positive Impact Experiences (PIEs) across its global portfolio and launches Made by Humans, a new hub celebrating the people, expertise and first-hand knowledge behind its adventures.
The Canadian government wants to ramp up the development and adoption of AI systems, starting with the health sector, but experts warn that proposed measures to address privacy concerns have critical gaps.
Egg freezing is surging in Canada and genetic testing is one of the motivations. We spoke with a woman planning to freeze her eggs so she can test her embryos for the BRCA 1 gene mutation.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.